Finance

Lists
SUPN:NASDAQ
Supernus Pharmaceuticals Inc
US$ ४२.८३
+०.१६%
(+०.०७०) 1D
US$ ४२.८३
०.००% (०.००)
After hours
Closed: अक्टोबर ६, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SUPN...
Open
US$ ४२.८६
High
US$ ४३.१२
Low
US$ ४१.४०
Mkt. cap
२.४७ अरब
Avg. vol.
६.२७ लाख
Volume
१३.००
52-wk high
US$ ५९.६८
52-wk low
US$ ४०.५१
EPS
-US$ १.९१
Beta
०.५५
Shares outstanding
५.८२ करोड
No. of employees
७७८
Open
US$ ४२.८६
High
US$ ४३.१२
Low
US$ ४१.४०
Mkt. cap
२.४७ अरब
Avg. vol.
६.२७ लाख
Volume
१३.००
52-wk high
US$ ५९.६८
52-wk low
US$ ४०.५१
EPS
-US$ १.९१
Beta
०.५५
Shares outstanding
५.८२ करोड
No. of employees
७७८
News stories
From web sources and news partners
About Supernus Pharmaceuticals Inc
CEOJack A. Khattar
Employees७७८
Founded२००५
HeadquartersRockville, मेरिल्यान्ड, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to SUPN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SUPN in the last 3 months.
Highest
Current US$ ४२.८३
US$ ६७.०० (+५६.४३%)
Average
US$ ६५.२० (+५२.२३%)
Lowest
US$ ६३.०० (+४७.०९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stacy Ku
TD Cowen
Buy
Maintained
US$ ६५.००
+५१.८%
08/03/2026
David Amsellem
Piper Sandler
Buy
Reiterated
US$ ६६.००
+५४.१%
07/27/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
US$ ६३.००
+४७.१%
07/13/2026
Chi Meng Fong
Bank of America Securities
Buy
Maintained
US$ ६३.००
+४७.१%
07/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ६५.००
+५१.८%
07/10/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
US$ ६७.००
+५६.४%
07/09/2026
Annabel Samimy
Stifel Nicolaus
Hold
Maintained
US$ ५५.००
+२८.४%
05/06/2026
Pavan Patel
Bank of America Securities
Buy
Maintained
US$ ६५.००
+५१.८%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१९.२१ करोड
२१.१६ करोड
२०.७७ करोड
२१.९१ करोड
Cost of goods sold
४.८३ करोड
५.०८ करोड
६.२८ करोड
६.३१ करोड
Cost of revenue
४.८३ करोड
५.०८ करोड
६.२८ करोड
६.३१ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
११.१० करोड
१२.४४ करोड
१२.६७ करोड
१३.६० करोड
Operating expense
१३.५३ करोड
१४.९० करोड
१५.२३ करोड
१६.१४ करोड
Total operating expenses
१८.३६ करोड
१९.९८ करोड
२१.५१ करोड
२२.४५ करोड
Operating income
८४.७५ लाख
१.१८ करोड
-७४.४१ लाख
-५४.४४ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-५.८० करोड
-१९.१४ लाख
-५९.५० लाख
-५.७६ करोड
EBT excluding unusual items
१.०८ करोड
१.४२ करोड
-५०.५९ लाख
-५१.२९ लाख
Income tax expense
-१.२८ करोड
२१.९१ लाख
-३६.५७ लाख
७.२३ लाख
Effective tax rate
२२.१५%
-११४.४७%
६१.४६%
-१.२५%
Other operating expenses
-
-
-
-
Net income
-४.५१ करोड
-४१.०५ लाख
-२२.९३ लाख
-५.८४ करोड
Net profit margin
-२३.४९%
-१.९४%
-१.१०%
-२६.६५%
Earnings per share
०.६१
०.८८
०.२१
०.५३
Interest and investment income
२२.७७ लाख
२४.६२ लाख
२३.८२ लाख
२६.३० लाख
Interest expense
-
-
-
-२३.१५ लाख
Net interest expenses
२२.७७ लाख
२४.६२ लाख
२३.८२ लाख
३.१५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
३.३३ करोड
३.६८ करोड
१.८७ करोड
२.०३ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू